ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 619961 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 619961; 2) Community: the network communities that were significantly associated with the response to NSC 619961; 3) Molecule: the relationships between components within communities and NSC 619961; 4) MDR: the compounds that were significantly associated with the NSC 619961.

NSC Compound Enrichment Correlation
NSC 703107 Null 0.0105972823829603 0.17270673
NSC 715775 11H-Indolo[1,2-b]indazolium, 11-[[4-(dimethylamino)phenyl]methylene]-6-methyl-, trifluoromethanesulfonate 0.0105972823829603 0.4955429
NSC 718579 Null 0.0105972823829603 0.35908286
NSC 718730 Null 0.0105972823829603 0.29957392
NSC 748909 Chonemorphine 0.0105972823829603 0.24851917
NSC 758662 Lovastatin [USAN] 0.0105972823829603 -0.13484623
NSC 760979 Null 0.0105972823829603 -0.0043322218
NSC 105827 SANGIVAMYCIN,-THIO 0.0105972823829604 0.26011154
NSC 146268 as-Triazine-3,5(2H,4H)-dione, 2-.beta.-D-ribofuranosyl-3-thio- 0.0105972823829604 0.13636953
NSC 149765 1,4-Pentanediamine, N4-(6-methoxy-8-quinolinyl)-, phosphate (1:2) (9CI) 0.0105972823829604 0.4079783
Total:133  Current:47    [First] [Prev] [Next] [Last]